Seven organisations come together to launch INDovation programme to incubate and commercialise Indian healthcare startups
The programme is supported by Pfizer, Atal Innovation Mission (AIM), NITI Aayog, Social Alpha, Foundation for Innovation and Technology Transfer (FITT), IIT-Delhi and AGNIi; with UN Health Innovation Exchange (UNHIEX) as knowledge partner
Ahead of the World Health Day, the Atal Innovation Mission (AIM), NITI Aayog, AGNIi, Foundation for Innovation and Technology Transfer (FITT), IIT-Delhi, Pfizer and Social Alpha have come together to launch the Pfizer INDovation programme to support breakthrough healthcare innovations by startups in India. Social Alpha is the core implementation partner responsible for executing the programme, a statement notified.
It also said that this is Version 2.0 of the Pfizer IIT-Delhi Innovation and IP Program. In Version 1, Pfizer successfully incubated nine healthcare innovators and supported 19 IP filings. Now, in the first year of Version 2.0, three winning startups each in the areas of oncology and digital health, will receive a grant of up to Rs 65 lakh each for product trials, pilot studies and product market launches to accelerate the lab-to-market journey of their innovation. This is one of the largest such programmes, both by grant value and partnerships, to focus on incubating and commercialising healthcare startups in the country.
AIM and NITI Aayog will provide the startups with access to their entire network of incubators and facilities via co-incubation and will also provide technical and strategic advisery to support both the programme and the startups. The Indian Institute of Technology, Delhi (IIT Delhi), will be the principal incubation partner while customised incubation support will be provided across technology incubation centres such as the IITs, other major technology institutes and incubation network of AIM across India. Social Alpha, as the implementation partner, will support start-ups to accelerate their lab-to-market journey, said the statement.
The programme is also being supported by AGNIi, PATH, AHPI, St Johns Research Institute, HCG Hospitals, Cytecare Hospitals, FICCI, UNHIEX, Google for Startups, Design Alpha, HIMSS, Marico Innovation Foundation and TenX2, noted the statement.
The statement also s